Filing Date | Form | Description | Issuer | View |
---|---|---|---|---|
424B5 |
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
Intellia Therapeutics, Inc. | ||
424B5 |
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
Intellia Therapeutics, Inc. | ||
424B5 |
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
Intellia Therapeutics, Inc. | ||
424B5 |
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
Intellia Therapeutics, Inc. | ||
424B5 |
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
Intellia Therapeutics, Inc. | ||
424B5 |
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
Intellia Therapeutics, Inc. | ||
424B5 |
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
Intellia Therapeutics, Inc. | ||
5 |
Annual filing director officer or owner of more than ten percent. |
Intellia Therapeutics, Inc. | ||
8-A12B |
Registration of certain classes of securities 12(b) of the Securities Exchange Act |
Intellia Therapeutics, Inc. | ||
8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. |
Data provided by Kaleidoscope.